Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepicastat for PTSD in Veterans
NCT00641511Phase 2Withdrawn
- Sponsor
- Michael E. DeBakey VA Medical Center
- Start
- Jun 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Nepicastat with Placebo (2 arms). Primary endpoint: Change from baseline in CAPS(D) hyperarousal scores at 6 weeks. Planned start Jun 2008; status: withdrawn.
02
Drugs
nepicastat
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00641511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641511.